Drug price spike

Price increase of a drug essential to prevent brain damage in babies with a rare form of epilepsy distresses parents and doctors in Canada. Please Note: In 2013, Novartis Pharmaceuticals divested Synacthen Depot. Currently, Mallinckrodt Pharmaceuticals is the manufacturer of Synacthen Depot. Novartis Pharmaceuticals is not responsible for any price increase.